1
|
Calcium plus vitamin D supplementation and the risk of colorectal cancer.
|
N Engl J Med
|
2006
|
8.73
|
2
|
Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women.
|
JAMA
|
2010
|
7.12
|
3
|
Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial.
|
JAMA
|
2006
|
6.51
|
4
|
Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.
|
JAMA
|
2004
|
5.35
|
5
|
Breast cancer after use of estrogen plus progestin in postmenopausal women.
|
N Engl J Med
|
2009
|
4.80
|
6
|
Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
|
JAMA
|
2003
|
4.03
|
7
|
Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.
|
Am J Epidemiol
|
2009
|
3.33
|
8
|
Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.
|
JAMA
|
2006
|
3.29
|
9
|
Oral bisphosphonate use and breast cancer incidence in postmenopausal women.
|
J Clin Oncol
|
2010
|
3.17
|
10
|
Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study.
|
Am J Epidemiol
|
2008
|
3.05
|
11
|
Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial.
|
JAMA
|
2006
|
2.97
|
12
|
Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.
|
Am J Epidemiol
|
2008
|
2.79
|
13
|
Frequency and predictive value of a mammographic recommendation for short-interval follow-up.
|
J Natl Cancer Inst
|
2003
|
2.64
|
14
|
Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study.
|
J Natl Cancer Inst
|
2013
|
2.45
|
15
|
Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial.
|
J Natl Cancer Inst
|
2007
|
2.37
|
16
|
Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
|
J Natl Cancer Inst
|
2007
|
2.36
|
17
|
Symptom experience after discontinuing use of estrogen plus progestin.
|
JAMA
|
2005
|
2.32
|
18
|
Calcium and vitamin D supplementation and cognitive impairment in the women's health initiative.
|
J Am Geriatr Soc
|
2012
|
2.30
|
19
|
Sex hormone levels and risk of breast cancer with estrogen plus progestin.
|
J Natl Cancer Inst
|
2013
|
1.60
|
20
|
Patterns and predictors of sexual activity among women in the Hormone Therapy trials of the Women's Health Initiative.
|
Menopause
|
2011
|
1.59
|
21
|
Prospective analysis of association between use of statins or other lipid-lowering agents and colorectal cancer risk.
|
Ann Epidemiol
|
2011
|
1.57
|
22
|
Clinical breast examination: practical recommendations for optimizing performance and reporting.
|
CA Cancer J Clin
|
2004
|
1.52
|
23
|
Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
|
Maturitas
|
2006
|
1.31
|
24
|
Recreational physical activity, body mass index, and survival in women with colorectal cancer.
|
Cancer Causes Control
|
2012
|
1.26
|
25
|
Nutrition and physical activity cancer prevention guidelines, cancer risk, and mortality in the women's health initiative.
|
Cancer Prev Res (Phila)
|
2014
|
1.26
|
26
|
The relationship between cognitive function and physical performance in older women: results from the women's health initiative memory study.
|
J Gerontol A Biol Sci Med Sci
|
2009
|
1.21
|
27
|
Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers.
|
J Natl Cancer Inst
|
2011
|
1.17
|
28
|
Incident invasive breast cancer, geographic location of residence, and reported average time spent outside.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.11
|
29
|
Colorectal cancer screening attitudes and practices preferences for decision making.
|
Am J Prev Med
|
2005
|
1.10
|
30
|
Effectiveness of telephone counseling for mammography: results from five randomized trials.
|
Prev Med
|
2002
|
1.08
|
31
|
Relationship of social support and social burden to repeated breast cancer screening in the women's health initiative.
|
Health Psychol
|
2004
|
1.08
|
32
|
Non-steroidal anti-inflammatory drugs and cancer risk in women: results from the Women's Health Initiative.
|
Int J Cancer
|
2014
|
1.03
|
33
|
The quality of colonoscopy services--responsibilities of referring clinicians: a consensus statement of the Quality Assurance Task Group, National Colorectal Cancer Roundtable.
|
J Gen Intern Med
|
2010
|
1.02
|
34
|
Adult stature and risk of cancer at different anatomic sites in a cohort of postmenopausal women.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
1.00
|
35
|
Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects.
|
Breast Cancer Res
|
2014
|
0.95
|
36
|
A randomized controlled trial of calcium plus vitamin D supplementation and risk of benign proliferative breast disease.
|
Breast Cancer Res Treat
|
2008
|
0.95
|
37
|
Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration Program.
|
Cancer
|
2013
|
0.92
|
38
|
Clinical case management and navigation for colonoscopy screening in an academic medical center.
|
Cancer
|
2013
|
0.90
|
39
|
Dietary glycemic load, glycemic index, and carbohydrate and risk of breast cancer in the Women's Health Initiative.
|
Nutr Cancer
|
2011
|
0.88
|
40
|
Relative effects of tamoxifen, raloxifene, and conjugated equine estrogens on cognition.
|
J Womens Health (Larchmt)
|
2010
|
0.88
|
41
|
Toward a positive aging phenotype for older women: observations from the women's health initiative.
|
J Gerontol A Biol Sci Med Sci
|
2012
|
0.87
|
42
|
Perceptions of risk factors for breast cancer and attitudes toward mammography among women who are current, ex- and non-smokers.
|
Women Health
|
2002
|
0.87
|
43
|
The association between NSAID use and colorectal cancer mortality: results from the women's health initiative.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
0.86
|
44
|
Effectiveness of women's telephone counseling and physician education to improve mammography screening among women who underuse mammography.
|
Ann Behav Med
|
2002
|
0.86
|
45
|
Alcohol and folate consumption and risk of benign proliferative epithelial disorders of the breast.
|
Int J Cancer
|
2007
|
0.86
|
46
|
Incidence of cervical cytological abnormalities with aging in the women's health initiative: a randomized controlled trial.
|
Obstet Gynecol
|
2006
|
0.85
|
47
|
Oral bisphosphonate use and colorectal cancer incidence in the Women's Health Initiative.
|
J Bone Miner Res
|
2013
|
0.84
|
48
|
Low-fat dietary pattern and risk of benign proliferative breast disease: a randomized, controlled dietary modification trial.
|
Cancer Prev Res (Phila)
|
2008
|
0.83
|
49
|
Colorectal cancer screening among users of county health centers and users of private physician practices.
|
Public Health Rep
|
2009
|
0.81
|
50
|
Body mass index and screening for colorectal cancer: gender and attitudinal factors.
|
Cancer Epidemiol
|
2012
|
0.79
|
51
|
Menstrual and reproductive history, postmenopausal hormone use, and risk of benign proliferative epithelial disorders of the breast: a cohort study.
|
Breast Cancer Res Treat
|
2008
|
0.79
|
52
|
Assessing screening quality in the CDC's Colorectal Cancer Screening Demonstration Program.
|
Cancer
|
2013
|
0.78
|
53
|
Mammography interval and breast cancer mortality in women over the age of 75.
|
Breast Cancer Res Treat
|
2014
|
0.77
|
54
|
Changes in the inflammatory potential of diet over time and risk of colorectal cancer in postmenopausal women.
|
Am J Epidemiol
|
2017
|
0.75
|
55
|
Perceptions of risk factors for colorectal cancer and colorectal cancer risk-related behaviors among current, ex-, and nonsmokers.
|
J Cancer Educ
|
2013
|
0.75
|
56
|
Re: Short-interval follow-up mammography: are we doing the right thing?
|
J Natl Cancer Inst
|
2003
|
0.75
|
57
|
Response to Annweiler and Beauchet.
|
J Am Geriatr Soc
|
2013
|
0.75
|
58
|
Bioavailable insulin-like growth factor-I as mediator of racial disparity in obesity-relevant breast and colorectal cancer risk among postmenopausal women.
|
Menopause
|
2016
|
0.75
|
59
|
Walking speed, physical activity, and breast cancer in postmenopausal women.
|
Eur J Cancer Prev
|
2014
|
0.75
|
60
|
Longitudinal association of hemostatic factors with risk for cancers of the breast, colorectum, and lung among postmenopausal women.
|
Eur J Cancer Prev
|
2016
|
0.75
|
61
|
Guidance at the many edges of evidence: position statements of the American College of Preventive Medicine.
|
Am J Prev Med
|
2002
|
0.75
|
62
|
Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study.
|
Menopause
|
2017
|
0.75
|